1. Market Research
  2. > Pharmaceutical Market Trends
Active Pharmaceutical Ingredient Market by type, manufacturer, synthesis, by product, drug, application - Global Forecast to 2025

Active Pharmaceutical Ingredient Market by type, manufacturer, synthesis, by product, drug, application - Global Forecast to 2025

  • September 2020
  • 320 pages
  • ID: 4612803
  • Format: PDF
  • MarketsandMarkets

Summary

Table of Contents

Search Inside

The global active pharmaceutical ingredients market is projected to reach USD 248.3 billion by 2025 from USD 187.3 billion in 2020, at a CAGR of 5.8% during the forecast period. Growth in the active pharmaceutical ingredients market is primarily driven by factors such as growing use of immunoglobulins in various therapeutic areas, increase in plasma collection (and the number of plasma collection centers), rising geriatric population, and the growing prevalence of respiratory diseases and alpha-1-antitrypsin deficiency (AATD). However, the high cost of plasma products, limited reimbursements, and the emergence of recombinant alternatives are expected to restrain the growth of this market to a certain extent during the forecast period.

Biotech APIs segment is expected to grow at the highest CAGR during the forecast period
On the basis of type of synthesis, the APIs market is categorized into synthetic APIs and biotech APIs.The synthetic APIs segment is estimated to account for the largest share in 2019.

However, the biotech APIs segment is expected to grow at a higher rate over the forecast period. Factors such as growing demand of biotech drugs due to their specificity in action, advancements in biotechnology, increase in the demand for monoclonal antibodies and their similarity with the natural biological compounds found in the human body influence the growth of this segment.

Monoclonal antibodies segment is expected to account for the largest share of the global APIs market, by product type.

Based on product, the biotech APIs market is segmented into monoclonal antibodies, hormones, cytokines, fusion proteins, therapeutic enzymes, vaccines and blood factors.In 2019, the monoclonal antibodies segment is estimated to account for the largest share of the APIs market.

Large share of monoclonal antibodies is due to their rising application in oncology and other therapeutic areas, increase in number of FDA approvals for innovative biopharmaceutical products and increasing investments and technical advances in R&D for development of various novel products.

North America will dominate the market during the forecast period.
Geographically, the active pharmaceutical ingredients market is segmented into North America, Europe, Asia, andRest of the World. In 2019, North America accounted for the largest share of the active pharmaceutical ingredients market, followed by Europe and the Asia. . The major factors driving the overall growth of the APIs market in this region include the growing prevalence of preventable chronic diseases, increasing government emphasis on generic drugs, escalating demand for biologics and specialty drugs, and technological advancements in the manufacturing processes of APIs.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type - Tier 1: 37%, Tier 2: 22%, and Tier 3: 41%
• By Designation - C-level: 25%, D-level: 20%, and Others: 55%
• By Region - North America: 40%, Europe: 27%, Asia: 20%, and RoW: 13%

List of Companies Profiled in the Report
• Pfizer, Inc. (US)
• Novartis Internationla AG (Switzerland)
• Sanofi (France)
• Boehringer Ingelheim (Germany)
• Bristol-Myers Squibb (US)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Eli Lilly and Company (US)
• GlaxoSmithKline plc (UK)
• Merck & Co., Inc. (US)
• Mylan N.V. (US)
• AbbVie Inc. (US)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• AstraZeneca (UK)
• Cipla, Inc. (India)
• Dr. Reddy’s Laboratories Ltd. (India)
• Sun Pharmaceutical Industries Ltd. (India)
• API Pharma Tech (India)
• BDR Pharmaceuticals Internationals Pvt. Ltd. (India)
• Sreepathi Pharmaceuticals Limited (India)
• Shilpa Medicare Limited (India)

Research Coverage:
This report provides a detailed picture of the global active pharmaceutical ingredients market. It aims at estimating the size and future growth potential of the market across different segments, such as type, type of manufacturer, type of synthesis, type of drug, application and region.. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total active pharmaceutical ingredients market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on active pharmaceutical ingredients offered by the top 25 players in the active pharmaceutical ingredients market. The report analyses the active pharmaceutical ingredients market based on the type, type of manufacturer, type of synthesis, type of drug, application and region..
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various active pharmaceutical ingredients across key geographic regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the active pharmaceutical ingredients market.
• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the active pharmaceutical ingredients market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Freeze-Drying/ Lyophilization Market by Type, Scale of operation, Application, Accessories - Global Forecast to 2025

  • $ 4950
  • October 2020
  • 172 pages

The global freeze-drying/lyophilization equipment market is projected to reach USD 7.3 billion by 2025 from USD 4.9 billion in 2020, at a CAGR of 8.2% from 2020 to 2025. The increasing demand for food ...

  • APAC
  • Pharmaceutical
  • Biotechnology
  • Industry analysis
  • Health Expenditure
  • Pharmaceutical Production

ref:plp2020

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on